🇺🇸 FDA
Pipeline program

Phase 1 Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancer

89402638GIC1001

Phase 1 other active

Quick answer

Phase 1 Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancer for Metastatic colorectal cancer and Gastric cancer is a Phase 1 program (other) at Janssen-Cilag International N.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Janssen-Cilag International N.V.
Indication
Metastatic colorectal cancer and Gastric cancer
Phase
Phase 1
Modality
other
Status
active

Clinical trials